DFIClass I
Total Spinal-Fluid, Antigen, Antiserum, Control
21 CFR 866.5860 / Immunology
DFI is the FDA product code for Total Spinal-Fluid, Antigen, Antiserum, Control, a class I device type, regulated under 21 CFR 866.5860. As of , FDA records hold 4 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- DFI
- Device name
- Total Spinal-Fluid, Antigen, Antiserum, Control
- Regulation
- 21 CFR 866.5860
- Device class
- Class I
- Review panel
- Immunology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 4
- Ingested recalls
- 0
Clearances, product code DFI
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1983 | 1 |
| 1984 | 2 |
| 1985 | 1 |
Applicants with the most clearances
Product code DFI| Applicant | Clearances |
|---|---|
| Canyon Diagnostics, Inc. | 1 |
| Intl. Diagnostic Technology | 1 |
| Isolab, Inc. | 1 |
| Somas Medical Industries, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
